Scancell unveils funding plans for exciting pipeline of next-generation cancer drugs In a separate announcement, the company said it was acquiring new technology from Nottingham University that will complement its current pipeline [View article] Wednesday 18 April 2018 18:15 Categories: Immunobody Media Coverage Modi-1 Moditope SCIB1 Year - 2018 Previous Post << >> Next Post